New drug strategy aims to stabilize blood pressure and protect kidneys after major heart surgery
NCT ID NCT06487585
Summary
This study is testing if a drug called Angiotensin II is a safe and effective first-choice treatment for dangerously low blood pressure in patients right after heart surgery. Researchers will compare it to standard treatments to see if it better protects patients' kidneys and hearts, and helps them recover faster. The goal is to find the best way to manage this common and serious complication to improve patient outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASODILATORY HYPOTENSION DURING OR AFTER CARDIAC SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Maryland St. Joseph Medical Center
RECRUITINGTowson, Maryland, 21204, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.